Report Detail
Global Osteoarthritis Drugs Market Growth 2019-2024
- RnM3411893 |
- 13 May, 2019 |
- Global |
- 131 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint, including analgesics, nonsteroidal anti-inflammatory drugs, corticosteroids, hyaluronic acid, and phase III drugs.
According to this study, over the next five years the Osteoarthritis Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Osteoarthritis Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Osteoarthritis Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Oral
Injection
External
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Johnson & Johnson
Pfizer
Eli Lilly
Abbott
GlaxoSmithKline
Sanofi
Flexion Therapeutics
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Osteoarthritis Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Osteoarthritis Drugs market by identifying its various subsegments.
Focuses on the key global Osteoarthritis Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Osteoarthritis Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Osteoarthritis Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Osteoarthritis Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Osteoarthritis Drugs Consumption 2014-2024
- 2.1.2 Osteoarthritis Drugs Consumption CAGR by Region
- 2.2 Osteoarthritis Drugs Segment by Type
- 2.2.1 Oral
- 2.2.2 Injection
- 2.2.3 External
- 2.3 Osteoarthritis Drugs Consumption by Type
- 2.3.1 Global Osteoarthritis Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Osteoarthritis Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Osteoarthritis Drugs Sale Price by Type (2014-2019)
- 2.4 Osteoarthritis Drugs Segment by Application
- 2.4.1 Hospital Pharmacies
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.5 Osteoarthritis Drugs Consumption by Application
- 2.5.1 Global Osteoarthritis Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Osteoarthritis Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Osteoarthritis Drugs Sale Price by Application (2014-2019)
3 Global Osteoarthritis Drugs by Manufacturers
- 3.1 Global Osteoarthritis Drugs Sales Market Share by Manufacturers
- 3.1.1 Global Osteoarthritis Drugs Sales by Manufacturers (2017-2019)
- 3.1.2 Global Osteoarthritis Drugs Sales Market Share by Manufacturers (2017-2019)
- 3.2 Global Osteoarthritis Drugs Revenue Market Share by Manufacturers
- 3.2.1 Global Osteoarthritis Drugs Revenue by Manufacturers (2017-2019)
- 3.2.2 Global Osteoarthritis Drugs Revenue Market Share by Manufacturers (2017-2019)
- 3.3 Global Osteoarthritis Drugs Sale Price by Manufacturers
- 3.4 Global Osteoarthritis Drugs Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
- 3.4.1 Global Osteoarthritis Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
- 3.4.2 Players Osteoarthritis Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Osteoarthritis Drugs by Regions
- 4.1 Osteoarthritis Drugs by Regions
- 4.1.1 Global Osteoarthritis Drugs Consumption by Regions
- 4.1.2 Global Osteoarthritis Drugs Value by Regions
- 4.2 Americas Osteoarthritis Drugs Consumption Growth
- 4.3 APAC Osteoarthritis Drugs Consumption Growth
- 4.4 Europe Osteoarthritis Drugs Consumption Growth
- 4.5 Middle East & Africa Osteoarthritis Drugs Consumption Growth
5 Americas
- 5.1 Americas Osteoarthritis Drugs Consumption by Countries
- 5.1.1 Americas Osteoarthritis Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Osteoarthritis Drugs Value by Countries (2014-2019)
- 5.2 Americas Osteoarthritis Drugs Consumption by Type
- 5.3 Americas Osteoarthritis Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Osteoarthritis Drugs Consumption by Countries
- 6.1.1 APAC Osteoarthritis Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Osteoarthritis Drugs Value by Countries (2014-2019)
- 6.2 APAC Osteoarthritis Drugs Consumption by Type
- 6.3 APAC Osteoarthritis Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Osteoarthritis Drugs by Countries
- 7.1.1 Europe Osteoarthritis Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Osteoarthritis Drugs Value by Countries (2014-2019)
- 7.2 Europe Osteoarthritis Drugs Consumption by Type
- 7.3 Europe Osteoarthritis Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Osteoarthritis Drugs by Countries
- 8.1.1 Middle East & Africa Osteoarthritis Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Osteoarthritis Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Osteoarthritis Drugs Consumption by Type
- 8.3 Middle East & Africa Osteoarthritis Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Osteoarthritis Drugs Distributors
- 10.3 Osteoarthritis Drugs Customer
11 Global Osteoarthritis Drugs Market Forecast
- 11.1 Global Osteoarthritis Drugs Consumption Forecast (2019-2024)
- 11.2 Global Osteoarthritis Drugs Forecast by Regions
- 11.2.1 Global Osteoarthritis Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Osteoarthritis Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Osteoarthritis Drugs Forecast by Type
- 11.8 Global Osteoarthritis Drugs Forecast by Application
12 Key Players Analysis
- 12.1 Johnson & Johnson
- 12.1.1 Company Details
- 12.1.2 Osteoarthritis Drugs Product Offered
- 12.1.3 Johnson & Johnson Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Johnson & Johnson News
- 12.2 Pfizer
- 12.2.1 Company Details
- 12.2.2 Osteoarthritis Drugs Product Offered
- 12.2.3 Pfizer Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Pfizer News
- 12.3 Eli Lilly
- 12.3.1 Company Details
- 12.3.2 Osteoarthritis Drugs Product Offered
- 12.3.3 Eli Lilly Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Eli Lilly News
- 12.4 Abbott
- 12.4.1 Company Details
- 12.4.2 Osteoarthritis Drugs Product Offered
- 12.4.3 Abbott Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Abbott News
- 12.5 GlaxoSmithKline
- 12.5.1 Company Details
- 12.5.2 Osteoarthritis Drugs Product Offered
- 12.5.3 GlaxoSmithKline Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 GlaxoSmithKline News
- 12.6 Sanofi
- 12.6.1 Company Details
- 12.6.2 Osteoarthritis Drugs Product Offered
- 12.6.3 Sanofi Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Sanofi News
- 12.7 Flexion Therapeutics
- 12.7.1 Company Details
- 12.7.2 Osteoarthritis Drugs Product Offered
- 12.7.3 Flexion Therapeutics Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Flexion Therapeutics News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Osteoarthritis Drugs . Industry analysis & Market Report on Osteoarthritis Drugs is a syndicated market report, published as Global Osteoarthritis Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Osteoarthritis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
